@article{08d127e6074f4093bb5f85fb0b494c8e,
title = "Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma",
keywords = "dordaviprone, dose optimization, H3 K27M mutation, ONC201",
author = "Yazmin Odia and Carl Koschmann and Vitanza, {Nicholas A.} and {De Blank}, Peter and Dolly Aguilera and Jeffrey Allen and Doured Daghistani and Matthew Hall and Ziad Khatib and Cassie Kline and Tobey Macdonald and Sabine Mueller and Faison, {Shamia L.} and Allen, {Joshua E.} and Naderer, {Odin J.} and Ramage, {Samuel C.} and Tarapore, {Rohinton S.} and McGovern, {Susan Lynne} and Soumen Khatua and Wafik Zaky and Gardner, {Sharon L.}",
note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published by Oxford University Press on behalf of the Society for Neuro-Oncology.",
year = "2024",
month = apr,
day = "1",
doi = "10.1093/neuonc/noae001",
language = "English",
volume = "26",
pages = "S155--S164",
journal = "Neuro-Oncology",
issn = "1522-8517",
number = "Supplement_2",
}